Clinical Trials Directory

Trials / Completed

CompletedNCT01741974

Study of Anti-atherosclerotic and Estrogen-like Activity of Karinat in Perimenopausal Women

Double-blinded Placebo-controlled Multicenter Study of Anti-atherosclerotic and Estrogen-like Activity of Karinat in Perimenopausal Women

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
340 (actual)
Sponsor
Institute for Atherosclerosis Research, Russia · Academic / Other
Sex
Female
Age
40 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate the anti-atherosclerotic and anti-climacteric action of natural drug Karinat based on phytoestrogen-rich botanicals in perimenopausal women.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTKarinat
DRUGPlaceboSugar pill manufactured to mimic Karinat 500 mg tablet

Timeline

Start date
2005-10-01
Primary completion
2012-06-01
Completion
2012-10-01
First posted
2012-12-05
Last updated
2012-12-06

Source: ClinicalTrials.gov record NCT01741974. Inclusion in this directory is not an endorsement.

Study of Anti-atherosclerotic and Estrogen-like Activity of Karinat in Perimenopausal Women (NCT01741974) · Clinical Trials Directory